Meghani K, Cooley LF, Choy B, Kocherginsky M, et al. First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guerin. Eur Urol 2022 Aug 22. pii: S0302-2838(22)02553.
PMID: 36008193